ChipCare’s initial focus is on infectious diseases, and HIV in particular, PAx has the ability to conduct tests typically performed on lab-based flow cytometer or bead array platforms.
Member count: 11-50
Total raised: $7.049999M
Founded date: 2009

Investors 1

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
09.03.2015Series A$5M-finsmes.co...
17.09.2013-$2.049999M-finsmes.co...

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
09.03.2015ChipCare C...ChipCare Corporation, a Toront...Canada-finsmes.co...
06.03.2015Funding ro...Nextdoor, YouMail, RockYou, Te...-Steven Loe...vator.tv/n...
17.09.2013ChipCare R...ChipCare, a Toronto, Canada-ba...Canada fu...-finsmes.co...